Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia

Aim: There is an unmet need in Japan for more optimal lipid-lowering therapy (LLT) for patients with homozygous familial hypercholesterolemia (HoFH) who respond inadequately to available drug therapies and/or apheresis, to achieve goals of low-density lipoprotein cholesterol (LDL-C) reduction by 50%...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada-Shiba, Mariko, Ikewaki, Katsunori, Nohara, Atsushi, Otsubo, Yoshihiko, Yanagi, Koji, Yoshida, Masayuki, Chang, Qing, Foulds, Pamela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392478/
https://www.ncbi.nlm.nih.gov/pubmed/28154305
http://dx.doi.org/10.5551/jat.38216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392478/
https://www.ncbi.nlm.nih.gov/pubmed/28154305
http://dx.doi.org/10.5551/jat.38216

Ejemplares similares